ORTHO EVRA (norelgestromin ethinyl estradiol) Label, NDA[removed]supplement 26 - Contraceptive patch - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2009-03-31 14:09:07 Reproductive system Contraceptive patch Evra Oral contraceptive formulations Ethinylestradiol Transdermal patch Norelgestromin Emergency contraception Estradiol Hormonal contraception Endocrine system Medicine		ORTHO EVRA (norelgestromin/ethinyl estradiol) Label, NDA[removed]supplement 26 Add to Reading List Source URL: www.accessdata.fda.gov Download Document from Source Website File Size: 605,74 KB Share Document on Facebook

	Package leaflet: Information for the user EVRA 203 micrograms/24 hours + 33.9 micrograms/24 hours transdermal patch norelgestromin/ethinyl estradiol Important things to know about combined hormonal contraceptives (CHCs): DocID: 1uZRy - View Document
	ORTHO EVRA ® (norelgestromin / ethinyl estradiol TRANSDERMAL SYSTEM) DocID: EIQr - View Document
	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ORTHO EVRA® safely and effectively. See full prescribing information for ORTHO EVRA. ORTHO EVRA (norelgestromin/eth DocID: CJDQ - View Document
	Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee December 9, 2011 Scott Monroe, MD DocID: Ci6x - View Document
	Microsoft PowerPoint - Ortho Evra Core Presentation with Backup Slides 9 Dec 2011 DocID: Chwq - View Document